AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteEupalinolide A, extracted from Eupatorium lindleyanum whole herb on the ground,Compositae round Ye Zelan dried parts on the ground.
More Information Supplier PageEupalinolide A, extracted from Eupatorium lindleyanum whole herb on the ground,Compositae round Ye Zelan dried parts on the ground.
More Information Supplier PageEupalinolide A, extracted from Eupatorium lindleyanum whole herb on the ground,Compositae round Ye Zelan dried parts on the ground.
More Information Supplier PageEupalinolide B was extracted from Eupatorium lindleyanum whole grass on the ground.
More Information Supplier PageEupalinolide B was extracted from Eupatorium lindleyanum whole grass on the ground.
More Information Supplier PageEupalinolide B was extracted from Eupatorium lindleyanum whole grass on the ground.
More Information Supplier PageEvacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
More Information Supplier PageEvacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
More Information Supplier PageEvacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
More Information Supplier PageEvacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
More Information Supplier PageEvacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.
More Information Supplier PageEverolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor.
More Information Supplier PageEverolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor.
More Information Supplier PageEverolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor.
More Information Supplier PageEverolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor.
More Information Supplier PageEverolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor.
More Information Supplier PageRaloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
More Information Supplier PageRaloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
More Information Supplier PageRaloxifene is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women.
More Information Supplier PageEvodiamine is a chemical extracted from the Tetradium family of plants. It acts primarily as a thermogenic and stimulant.
More Information Supplier PageEvodiamine is a chemical extracted from the Tetradium family of plants. It acts primarily as a thermogenic and stimulant.
More Information Supplier PageEVP-6124 is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs); shows selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs); shows selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs); shows selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 hydrochloride is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs). EVP-6124 showed selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 hydrochloride is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs). EVP-6124 showed selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEVP-6124 hydrochloride is a novel partial agonist of ??7 neuronal nicotinic acetylcholine receptors (nAChRs). EVP-6124 showed selectivity for ??7 nAChRs and did not activate or inhibit heteromeric ??4??2 nAChRs.
More Information Supplier PageEW-7197 is a highly potent, selective, and orally bioavailable TGF-?? I receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively
More Information Supplier PageEW-7197 is a highly potent, selective, and orally bioavailable TGF-?? I receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively
More Information Supplier PageEW-7197 is a highly potent, selective, and orally bioavailable TGF-?? I receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively
More Information Supplier PageEW-7197 is a highly potent, selective, and orally bioavailable TGF-?? I receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively
More Information Supplier PageEX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor.
More Information Supplier PageEX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor.
More Information Supplier PageEX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor.
More Information Supplier PageEX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor.
More Information Supplier PageEX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor.
More Information Supplier PageExatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death.
More Information Supplier PageExatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death.
More Information Supplier PageExatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death.
More Information Supplier PageExatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death.
More Information Supplier PageExemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
More Information Supplier PageExemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
More Information Supplier PageExemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
More Information Supplier PageExemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
More Information Supplier PageExemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
More Information Supplier PageExherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities.
More Information Supplier Page
